Started in 2013 by a group of Gen Next technocrats from one of the earliest start-up cohorts inspired by the initiatives taken by BIRAC and Vision Group of Karnataka, Denovo Biolabs has come a long way to be the first Indian company to manufacture ELISA Kits for Pharmacokinetics and Immunogenicity for the Global Biosimilar Industry, used by 6 of the top 10 biosimilar companies in India. We offer cutting-edge products for R&D, drug development for large molecule therapeutics, biosimilar drug development and human diagnostics. Passion for Innovation, Commitment to Quality and Excellence in Service have been the hallmarks of Denovo Biolabs. Having developed and accumulated a wide range of products, capabilities, and capacities together with customer confidence and market traction, Denovo Biolabs is on the cusp of an exponential growth phase.
He is an active team member of management in strategizing the business of the company. He is also a key member for cost effective negotiatio…
Mr. Hari Kumar Is a seasoned Life sciences professional for over 30 years. He has been into Devises, reagents and consumables and has introd…
With a doctoral degree in Biotechnology and PGDB from Institute of Bioinformatics and applied Biotechnology, Bangalore (IBAB). He has more t…
She did her Post-Doctoral Research from University of Texas Medical Branch (UTMB) at Galveston, TX, USA, National Institute on Aging (NIA/NI…
He completed is bachelor’s in Commerce from University of Rajasthan. He has vast industrial experience of more than 30 years at various mana…
Every check below comes straight from official government records — badges here can't be bought.
Partially verified — 7 of 10 criteria met
DE NEUF BIO SYNC PRIVATE LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
DE NEUF BIO SYNC PRIVATE LIMITED is a government-verified manufacturer of metals & chemicals based in Mumbai City, Maharashtra, India. It was incorporated in 2018 per Ministry of Corporate Affairs records (CIN U24304MH2018PTC306791). BharatSeal verifies it against MCA — official Indian government registries. Its BharatSeal trust score is 50 out of 100.
Global Biosimilar Industry, Drug Development, Human Diagnostics, Biopharma
Mumbai City, MH, India
Yes — verified across MCA (government registries including MCA, GSTN). CIN: U24304MH2018PTC306791.
DE NEUF BIO SYNC PRIVATE LIMITED was incorporated in 2018 per Ministry of Corporate Affairs records under CIN U24304MH2018PTC306791. The company has been operating for 8 years, with the registration auditable on mca.gov.in.
DE NEUF BIO SYNC PRIVATE LIMITED's current directors include Dinesh Kumar Saini, Manjunath S Devaramani, Arpita Chatterjee, and 1 other. Director records are sourced from the MCA21 corporate registry and reflect the latest filing with the Ministry of Corporate Affairs.
50 out of 100. BharatSeal's trust score is computed from the breadth of government registrations the entity carries (MCA + GSTN + Udyam + IEC + EPFO), the freshness of those records, and the entity's interaction history on the platform (orders completed, on-time delivery rate, dispute outcomes). Buyers use this number to triage suppliers at scale.
Send an inquiry through BharatSeal — verified suppliers typically respond within 2 hours, often on WhatsApp. Every enquiry is logged so you have a record of the conversation.
Other verified manufacturers in the same network — discovered via MCA21 cross-references.